SP-MHCI-0472-3

Human CMV pp65 320-328, LMNGQQIFL

US$507.00

In stock

Description

About Human CMV pp65 320-328, LMNGQQIFL

The Human Cytomegalovirus (HCMV) (strain AD169) 65 kDa phosphoprotein (pp65) Peptide (IEDB: 38079) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The 65 kDa phosphoprotein (pp65) Peptide, H-LMNGQQIFL-OH (Uniprot: P06725 aa: 320-328) from JPT is produced under strict quality control and quality management.

Human CMV pp65 320-328, LMNGQQIFL - Specifications

  • Peptide sequence: H-LMNGQQIFL-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human CMV pp65 320-328, LMNGQQIFL

References:
Read References with JPT’s Antigen Peptides
Human CMV pp65 320-328, LMNGQQIFL has been described in:
Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers., J Virol, 2003 (PMID: 12692225)
The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice., J Immunol, 2011 (PMID: 21810614)
Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines., Eur J Immunol, 2015 (PMID: 25631937)

Documentation

Documentation for Human CMV pp65 320-328, LMNGQQIFL

Properties

Properties of Human CMV pp65 320-328, LMNGQQIFL

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Infection
Layout: Freeze-dried in glass vial
Organism: Human Cytomegalovirus (HCMV)
Protein Name: 65 kDa phosphoprotein (pp65)
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human CMV pp65 320-328, LMNGQQIFL

Information Values
Sequence: H-LMNGQQIFL-OH
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote